Literature DB >> 23724634

A case of hereditary spherocytosis misdiagnosed as pyruvate kinase deficient hemolytic anemia.

Cristina Vercellati1, Anna Paola Marcello, Elisa Fermo, Wilma Barcellini, Alberto Zanella, Paola Bianchi.   

Abstract

BACKGROUND: Hereditary spherocytosis (HS) and pyruvate kinase (PK) deficiency are the most common causes of congenital hemolytic anemia. We describe a case of HS with defective PK activity initially misdiagnosed as PK deficiency.
METHODS: Hematologic investigation, SDS-PAGE analysis of red cell membrane proteins and sequencing of the PKLR gene were performed.
RESULTS: The molecular characterization of the PKLR gene showed a heterozygous mutation 994G > A (Gly332Ser) associated with the promoter substitution -148C > T, whose role in the pathophysiology of PK deficiency is debated. Further investigations revealed spectrin deficiency; the family study demonstrated that the hemolysis was exclusively attributable to HS.
CONCLUSIONS: The present case pinpoints to the need for extensive family investigations to correctly diagnose chronic hemolytic anemia, in particular when molecular characterization does not fully explain the clinical phenotype.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23724634

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  7 in total

1.  Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency.

Authors:  Paola Bianchi; Elisa Fermo; Bertil Glader; Hitoshi Kanno; Archana Agarwal; Wilma Barcellini; Stefan Eber; James D Hoyer; David J Kuter; Tabita Magalhães Maia; Maria Del Mar Mañu-Pereira; Theodosia A Kalfa; Serge Pissard; José-Carlos Segovia; Eduard van Beers; Patrick G Gallagher; David C Rees; Richard van Wijk
Journal:  Am J Hematol       Date:  2018-11-28       Impact factor: 10.047

2.  The proteomic and genomic teratogenicity elicited by valproic acid is preventable with resveratrol and α-tocopherol.

Authors:  Yeh Chen; Ping-Xiao Lin; Chiu-Lan Hsieh; Chiung-Chi Peng; Robert Y Peng
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

3.  Hereditary Xerocytosis due to Mutations in PIEZO1 Gene Associated with Heterozygous Pyruvate Kinase Deficiency and Beta-Thalassemia Trait in Two Unrelated Families.

Authors:  Elisa Fermo; Cristina Vercellati; Anna Paola Marcello; Anna Zaninoni; Richard van Wijk; Nadia Mirra; Cristina Curcio; Agostino Cortelezzi; Alberto Zanella; Wilma Barcellini; Paola Bianchi
Journal:  Case Rep Hematol       Date:  2017-03-06

4.  Concomitant Hereditary Spherocytosis and Pyruvate Kinase Deficiency in a Spanish Family with Chronic Hemolytic Anemia: Contribution of Laser Ektacytometry to Clinical Diagnosis.

Authors:  Joan-Lluis Vives Corrons; Elena Krishnevskaya; Laura Montllor; Valentina Leguizamon; Marta Garcia Bernal
Journal:  Cells       Date:  2022-03-28       Impact factor: 6.600

5.  How will next generation sequencing (NGS) improve the diagnosis of congenital hemolytic anemia?

Authors:  Paola Bianchi; Cristina Vercellati; Elisa Fermo
Journal:  Ann Transl Med       Date:  2020-03

Review 6.  Molecular heterogeneity of pyruvate kinase deficiency.

Authors:  Paola Bianchi; Elisa Fermo
Journal:  Haematologica       Date:  2020-09-01       Impact factor: 9.941

7.  Untargeted metabolic profiling in dried blood spots identifies disease fingerprint for pyruvate kinase deficiency.

Authors:  Birgit Van Dooijeweert; Melissa H Broeks; Nanda M Verhoeven-Duif; Eduard J Van Beers; Edward E S Nieuwenhuis; Wouter W Van Solinge; Marije Bartels; Judith J Jans; Richard Van Wijk
Journal:  Haematologica       Date:  2021-10-01       Impact factor: 9.941

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.